Stops along the RAS pathway in human genetic disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature Medicine

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm0306-283PMID 16520774
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Compartmentalized Ras/MAPK signaling.

  2006cited by this paper
• Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

  2006cited by this paper
• BRAF mutation predicts sensitivity to MEK inhibition

  2006cited by this paper
• Germline KRAS mutations cause Noonan syndrome

  2006cited by this paper
• PTPN11 (Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects*

  2006cited by this paper
• Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.

  2005cited by this paper
• Diverse Biochemical Properties of Shp2 Mutants

  2005cited by this paper
• Coordinating ERK/MAPK signalling through scaffolds and inhibitors

  2005cited by this paper
• Germline mutations in HRAS proto-oncogene cause Costello syndrome

  2005cited by this paper
• Noonan syndrome and related disorders: genetics and pathogenesis.

  2005cited by this paper
• Dysregulation of the TSC-mTOR pathway in human disease

  2004cited by this paper
• Mouse model of Noonan syndrome reveals cell type– and gene dosage–dependent effects of Ptpn11 mutation

  2004cited by this paper
• Targeting the mitogen-activated protein kinase cascade to treat cancer

  2004cited by this paper
• Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

  2004cited by this paper
• NF1 tumor suppressor gene function: narrowing the GAP.

  2001cited by this paper

• Q241R mutation of Braf causes neurological abnormalities in a mouse model of cardio-facio-cutaneous syndrome, independent of developmental malformations.

  2025cites this paper
• Pax6 affects Ras-Raf-ERK1/2 in mouse aging brain

  2023cites this paper
• RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis

  2023cites this paper
• [Phosphorylation of Smurf2 at Thr249 by Erk5 regulates TGF-β signaling].

  2021cites this paper
• Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives

  2020cites this paper
• H-Ras induces Nrf2-Pin1 interaction: Implications for breast cancer progression.

  2020cites this paper
• Increased nuchal translucency: it’s not just aneuploidy

  2020cites this paper
• The Protein Tyrosine Phosphatase Receptor Delta Regulates Developmental Neurogenesis.

  2020cites this paper
• Pulmonary Hypertension in the RASopathies

  2019cites this paper
• The impact of RASopathy-associated mutations on CNS development in mice and humans

  2019cites this paper
• Excitatory neuron–specific SHP2-ERK signaling network regulates synaptic plasticity and memory

  2019cites this paper
• Getting "Ras"-ults: Solving Molecular Promiscuity through Microdomain-Selective Targeting.

  2018cites this paper
• Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis

  2018cites this paper
• From microcephaly to megalencephaly: determinants of brain size

  2018cites this paper
• Congenital Heart Diseases in Noonan’s Syndrome – Mitral Valve Anomalies: Important Cause of Left Ventricular Outflow Tract Obstruction

  2018cites this paper
• The MAPK Erk5 is necessary for proper skeletogenesis through a molecular axis that involves Smurfs-Smads-Sox9

  2018cites this paper
• Edinburgh Research Explorer The INT6 cancer gene and MEK signaling pathways converge during zebrafish development

  2018cites this paper
• The MAPK Erk5 is necessary for proper skeletogenesis involving a Smurf-Smad-Sox9 molecular axis

  2018cites this paper
• FOXI2: a possible gene contributing to ectodermal dysplasia

  2017cites this paper
• Noonan syndrome: lessons learned from genetically modified mouse models

  2017cites this paper
• Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models

  2017cites this paper
• Explorer The INT 6 cancer gene and MEK signaling pathways converge during zebrafish development

  2017cites this paper
• Modeling RASopathies with Genetically Modified Mouse Models.

  2017cites this paper
• Chronic impairment of ERK signaling in glutamatergic neurons of the forebrain does not affect spatial memory retention and LTP in the same manner as acute blockade of the ERK pathway

  2017cites this paper
• Maxillofacial Features In Patients With Noonan Syndrome

  2017cites this paper
• Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.

  2017cites this paper
• Abbreviated Title : The effect of chronic disruption of ERK signaling on the hippocampus

  2017cites this paper
• Cell type-specific roles of RAS-MAPK signaling in learning and memory: Implications in neurodevelopmental disorders.

  2016cites this paper
• Investigation of the mechanisms terminating growth factor induced Ras activation

  2016cites this paper
• Retinoic-acid-mediated HRas stabilization induces neuronal differentiation of neural stem cells during brain development

  2016cites this paper
• Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities

  2016cites this paper
• Cutaneous-Skeletal Hypophosphatemia Syndrome is a Multilineage Somatic Mosaic RAS opathy

  2016cites this paper
• Spectrum of Genetic Diseases and Management

  2016cites this paper
• Induced Pluripotent Stem Cells for Cardiac Regeneration

  2016cites this paper
• Feedback activation of neurofibromin terminates growth factor-induced Ras activation

  2016cites this paper
• Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.

  2016cites this paper
• Enhanced SMAD1 Signaling Contributes to Impairments of Early Development in CFC‐iPSCs

  2015cites this paper
• Transient Blockade of ERK Phosphorylation in the Critical Period Causes Autistic Phenotypes as an Adult in Mice

  2015cites this paper
• Proliferation and arrest: the genetics of orbital disorders

  2015cites this paper
• Dentate Gyrus Development Requires ERK Activity to Maintain Progenitor Population and MAPK Pathway Feedback Regulation

  2015cites this paper
• A proteomic approach to understand MMP‐3‐driven developmental processes in the postnatal cerebellum: Chaperonin CCT6A and MAP kinase as contributing factors

  2015cites this paper
• Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: Clinical and molecular findings in 11 patients

  2015cites this paper
• Expanding the genetics of microcephalic primordial dwarfism

  2015cites this paper
• [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].

  2015cites this paper
• Portrait of the PI3K/AKT pathway in colorectal cancer.

  2015cites this paper
• Tumors of the Adrenal Gland

  2015cites this paper
• Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways

  2015cites this paper
• Prognostic role of BRAF in human cutaneous melanoma : gene versus protein expression

  2015cites this paper
• The Tumor Suppressor RASSF1A Links Inflammation and Cancer

  2015cites this paper
• The impact of the genetic background in the Noonan syndrome phenotype induced by K-RasV14I

  2015cites this paper
• Functions of P38 and ERK kinases in zebrafish early development

  2014cites this paper
• Diagnosis of Noonan syndrome and related disorders using target next generation sequencing

  2014cites this paper
• Structure‐energy‐based predictions and network modelling of RASopathy and cancer missense mutations

  2014cites this paper
• SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia

  2014cites this paper
• [PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex].

  2014cites this paper
• SRF regulates craniofacial development through selective recruitment of MRTF cofactors by PDGF signaling.

  2014cites this paper
• SHP-2 deletion in postmigratory neural crest cells results in impaired cardiac sympathetic innervation

  2014cites this paper
• A systems biology road map for the discovery of drugs targeting cancer cell metabolism.

  2014cites this paper
• Functional Insights Into Oncogenic Protein Tyrosine Phosphatases By Mass Spectrometry

  2014influential citation
• The P38αA and Erk2 are essential for epiboly initiation by regulating common and separate developmental genetic programs

  2014cites this paper
• The Protein Tyrosine Phosphatase Shp2 Is Required for the Generation of Oligodendrocyte Progenitor Cells and Myelination in the Mouse Telencephalon

  2014cites this paper
• Globularity and language-readiness: generating new predictions by expanding the set of genes of interest

  2014cites this paper
• Conserved Molecular Factors: Role of the Snail Family of Transcription Factors and the Fat Family of Atypical Cadherins in Cortical Development

  2014cites this paper
• Genome-wide gene expression in a patient with 15q13.3 homozygous microdeletion syndrome

  2013cites this paper
• Heart defects and other features of the 22q11 distal deletion syndrome.

  2013influential citation
• Probiotic Supplementation Promotes Calcification in Danio rerio Larvae: A Molecular Study

  2013cites this paper
• PKC-epsilon activation is required for recognition memory in the rat.

  2013cites this paper
• The other side of Turner's: Noonan's syndrome

  2013cites this paper
• MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response

  2013cites this paper
• Characterization of hereditary cancer syndromes

  2013cites this paper
• Síndrome de Noonan y riesgo de hipertermia maligna: anestesia total intravenosa para cirugía pediátrica ambulatoria

  2013cites this paper
• Ulerythema Ophryogenes, A Rarely Reported Cutaneous Manifestation of Noonan Syndrome: Case Report and Review of the Literature

  2013cites this paper
• Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer.

  2013cites this paper
• CONFORMATIONAL DYNAMICS OF K-RAS AND H-RAS PROTEINS: IS THERE FUNCTIONAL SPECIFICITY AT THE CATALYTIC DOMAIN?

  2013cites this paper
• LEOPARD Syndrome: Clinical Features and Gene Mutations

  2012cites this paper
• Cross-Regulation of JAK-STAT Signaling: Implications for Approaches to Combat Chronic Inflammatory Diseases and Cancers

  2012cites this paper
• Increased BRAF Heterodimerization Is the Common Pathogenic Mechanism for Noonan Syndrome-Associated RAF1 Mutants

  2012cites this paper
• Human-Induced Pluripotent Stem Cells: In Quest of Clinical Applications

  2012cites this paper
• Growth standards of patients with Noonan and Noonan‐like syndromes with mutations in the RAS/MAPK pathway

  2012cites this paper
• Analyse der Auswirkungen von Aminosäuresubstitutionen im humanen CBL-Protein auf die Regulation des epidermalen Wachstumsfaktorrezeptors (EGFR)

  2012cites this paper
• Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes

  2012influential citation
• Syndrome LEOPARD et carcinome épidermoïde labial : présentation d’un cas

  2012cites this paper
• Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia.

  2012cites this paper
• Two novel germline KRAS mutations: expanding the molecular and clinical phenotype

  2012cites this paper
• Sotos Syndrome Is Associated with Deregulation of the MAPK/ERK-Signaling Pathway

  2012cites this paper
• An investigation of the role of two novel cancer targets, P-Rex1 and FAK, in genetically modified mouse models of melanoma

  2012cites this paper
• ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.

  2012cites this paper
• MAPK Signaling Determines Anxiety in the Juvenile Mouse Brain but Depression-Like Behavior in Adults

  2012cites this paper
• MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.

  2011cites this paper
• Specific functions for ERK/MAPK signaling during PNS development.

  2011cites this paper
• Bedeutung eines neuen IGF-1-Rezeptor- Tyrosinkinase-Inhibitors für Zellproliferation, Signaltransduktion und Regulation der Sekretion in neuroendokrinen Tumorzellen

  2011cites this paper
• FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation

  2011cites this paper
• Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: A review

  2011cites this paper
• RASSF1A: Not a prototypical Ras effector.

  2011cites this paper
• RASSF1A

  2011cites this paper
• Signalling Pathways in Development and Human Disease: A Drosophila Wing Perspective

  2011influential citation
• [Targeting the RAS signalling pathway in cancer].

  2011cites this paper
• High‐Resolution genomic arrays identify CNVs that phenocopy the chromosome 22q11.2 deletion syndrome

  2011cites this paper
• Non-Hodgkin Lymphoma in a Patient With Cardiofaciocutaneous Syndrome

  2011cites this paper
• BRAF Gene Deletion Broadens the Clinical Spectrum Neuro-Cardio-Facial-Cutaneous Syndromes

  2011cites this paper